Vicore Pharma Holding AB (OSTO:VICO) OCF Yield %: -11.70 (As of Jun. 29, 2026)


OSTO:VICO Vicore Pharma Holding AB OSTO:VICO
28 GF Score
Price kr12.32
! 5 Warning Signs
View Full Analysis

What is Vicore Pharma Holding AB OCF Yield %?

Vicore Pharma Holding AB OSTO:VICO +1.65% 28 OCF Yield % is -11.70 as of Jun. 29, 2026. GuruFocus rates OSTO:VICO with a GF Score™ of 28/100. The stock has 5 warning signs investors should review. Among 1,417 Biotechnology companies, Vicore Pharma Holding AB ranks worse than 57.09% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Vicore Pharma Holding AB's Trailing 12-Month Cash Flow from Operations is kr-405.96 Mil, and Market Cap is kr3,468.40 Mil. Therefore, Vicore Pharma Holding AB's OCF Yield % for today is -11.70%.

The historical rank and industry rank for Vicore Pharma Holding AB's OCF Yield % or its related term are showing as below:

OSTO:VICO' s OCF Yield % Range Over the Past 10 Years
Min: -26.99   Med: -10.19   Max: -1.33
Current: -11.7

During the past 13 years, the highest OCF Yield % of Vicore Pharma Holding AB was -1.33%. The lowest was -26.99%. And the median was -10.19%.

OSTO:VICO's OCF Yield % is ranked worse than
57.09% of 1417 companies
in the Biotechnology industry
Industry Median: -8.4 vs OSTO:VICO: -11.70

Vicore Pharma Holding AB's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Vicore Pharma Holding AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Vicore Pharma Holding AB OCF Yield % Related Terms

Vicore Pharma Holding AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Vicore Pharma Holding AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicore Pharma Holding AB OCF Yield % Chart

Vicore Pharma Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.55 -20.47 -15.75 -8.32 -11.81

Vicore Pharma Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.83 -23.85 -12.83 -10.24 -16.71

OSTO:VICO vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Vicore Pharma Holding AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicore Pharma Holding AB OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's OCF Yield % falls into.


OSTO:VICO
28GF Score
Vicore Pharma Holding AB OSTO:VICO
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vicore Pharma Holding AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Vicore Pharma Holding AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-375.737 / 3181.2438
=-11.81%

Vicore Pharma Holding AB's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-117.641 * 4 / 2815.26
=-16.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -11.70 mean?
Vicore Pharma Holding AB (OSTO:VICO) has a OCF Yield % of -11.70 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vicore Pharma Holding AB and its competitors. According to the industry distribution chart, Vicore Pharma Holding AB ranks #809 out of 1417 companies in the Biotechnology industry, placing it in the top 57.1%.
Is Vicore Pharma Holding AB's OCF Yield % too high?
Vicore Pharma Holding AB's current OCF Yield % is -11.70. Based on the distribution chart, Vicore Pharma Holding AB ranks #809 out of 1417 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Vicore Pharma Holding AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Vicore Pharma Holding AB's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vicore Pharma Holding AB ranks #809 out of 1417 companies for OCF Yield %. This places Vicore Pharma Holding AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vicore Pharma Holding AB and its competitors. Vicore Pharma Holding AB's current OCF Yield % is -11.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicore Pharma Holding AB stock overvalued right now?
Vicore Pharma Holding AB (OSTO:VICO) has a current OCF Yield % of -11.70. The current OCF Yield % is -11.70. Vicore Pharma Holding AB's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Vicore Pharma Holding AB (OSTO:VICO), the current OCF Yield % is -11.70 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicore Pharma Holding AB Business Description

Other Exchanges 6Y4:Germany
Address Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
28GF Score

Get the complete analysis for OSTO:VICO

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.32
Price